| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
126,890,000 |
| Market
Cap: |
1.15(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$9.07 - $9.1 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile CTI BioPharma is a biopharmaceutical company focused on the acquisition, development and commercialization of targeted therapies for blood-related cancers where there is an unmet medical need. Co. has one commercially approved product, VONJO™ (pacritinib), which has received approval in the U.S. by the U.S. Food and Drug Administration for the treatment of adult patients with intermediate or primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis with a platelet count below 50 x 10^9/L.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
5,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$27,500 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
0 |
0 |
0 |
9,840,628 |
| Total Sell Value |
$0 |
$0 |
$0 |
$60,171,858 |
| Total People Sold |
0 |
0 |
0 |
5 |
| Total Sell Transactions |
0 |
0 |
0 |
25 |
| End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Singer Jack W |
EVP, Chief Medical Officer |
• • – |
2005-07-01 |
4 |
AS |
$2.70 |
$8,640 |
D/D |
(3,200) |
441,716 |
|
- |
|
| Bianco Louis A |
EVP, Finance & Administration |
• – – |
2005-07-01 |
4 |
AS |
$2.70 |
$10,800 |
D/D |
(4,000) |
208,397 |
|
- |
|
| Bianco James A |
President and CEO |
• • – |
2005-07-01 |
4 |
AS |
$2.70 |
$25,988 |
D/D |
(9,625) |
672,347 |
|
- |
|
| Aselage Steve |
EVP, Global Commercial Ops |
• – – |
2005-06-30 |
4 |
D |
$0.00 |
$0 |
D/D |
(106,667) |
24,133 |
|
- |
|
| Bianco James A |
President and CEO |
• • – |
2005-05-31 |
4 |
S |
$2.95 |
$53,100 |
D/D |
(18,000) |
681,972 |
|
- |
|
| Bianco James A |
President and CEO |
• • – |
2005-04-05 |
4 |
S |
$3.68 |
$110,600 |
D/D |
(30,000) |
699,972 |
|
- |
|
| Canfield James |
Chief Administrative Officer |
• – – |
2005-04-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(116,667) |
39,499 |
|
- |
|
| Fluke John M Jr |
Director |
– • – |
2005-03-14 |
4 |
B |
$4.00 |
$20,000 |
D/D |
5,000 |
10,000 |
2.39 |
- |
|
| Link Max |
Director |
– • – |
2005-03-10 |
4 |
B |
$5.20 |
$26,000 |
D/D |
5,000 |
73,572 |
2.39 |
- |
|
| Singer Jack W |
EVP, Chief Medical Officer |
• • – |
2005-03-01 |
4 |
AS |
$9.93 |
$74,875 |
D/D |
(7,500) |
444,178 |
|
- |
|
| Singer Jack W |
EVP, Chief Medical Officer |
• • – |
2005-03-01 |
4 |
OE |
$2.91 |
$21,795 |
D/D |
7,500 |
444,878 |
|
- |
|
| Singer Jack W |
EVP, Chief Medical Officer |
• • – |
2005-02-01 |
4 |
AS |
$9.98 |
$74,850 |
D/D |
(7,500) |
444,178 |
|
- |
|
| Singer Jack W |
EVP, Chief Medical Officer |
• • – |
2005-02-01 |
4 |
OE |
$2.91 |
$21,795 |
D/D |
7,500 |
451,678 |
|
- |
|
| Leigh Richard Jr |
Exec. V.P., General Counsel |
• – – |
2005-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
113,300 |
|
- |
|
| Aselage Steve |
EVP Global Comm Operations |
• – – |
2005-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
130,800 |
|
- |
|
| Singer Jack W |
EVP, Chief Medical Officer |
• • – |
2005-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
444,178 |
|
- |
|
| Canfield James |
Chief Administrative Officer |
• – – |
2005-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
156,166 |
|
- |
|
| Bianco Louis A |
EVP, Finance & Administration |
• – – |
2005-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
212,397 |
|
- |
|
| Bianco James A |
President and CEO |
• • – |
2005-01-10 |
4 |
A |
$0.00 |
$0 |
D/D |
200,000 |
729,972 |
|
- |
|
| Spinelli Silvano |
EVP, Development |
• • – |
2005-01-04 |
4 |
AS |
$7.76 |
$311,941 |
D/D |
(40,000) |
320,760 |
|
- |
|
| Singer Jack W |
EVP, Chief Medical Officer |
• • – |
2005-01-03 |
4 |
AS |
$8.01 |
$25,780 |
D/D |
(3,200) |
343,676 |
|
- |
|
| Canfield James |
Chief Administrative Officer |
• – – |
2005-01-03 |
4 |
AS |
$8.01 |
$8,023 |
D/D |
(1,000) |
56,166 |
|
- |
|
| Bianco Louis A |
EVP, Finance & Administration |
• – – |
2005-01-03 |
4 |
AS |
$8.13 |
$32,569 |
D/D |
(4,000) |
112,397 |
|
- |
|
| Bianco James A |
President and CEO |
• • – |
2005-01-03 |
4 |
AS |
$8.06 |
$77,578 |
D/D |
(9,625) |
564,972 |
|
- |
|
| Bianco James A |
President and CEO |
• • – |
2004-12-30 |
4 |
GD |
$0.00 |
$0 |
D/D |
35,000 |
529,972 |
|
- |
|
742 Records found
|
|
Page 28 of 30 |
|
|
